SRRKScholar Rock Holding Corporation

$5B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$672,000

Operating Income

-$48M

Net Income

-$46M

EPS (Diluted)

$-0.61

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$37M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$311M

Total Liabilities

$86M

Stockholders' Equity

$225M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$672,000	-$3M	+73.4%
Operating Income	-$48M	-$40M	-18.8%
Net Income	-$46M	-$39M	-17.5%

SRRK Q4 2023 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena